Symplmed Pharmaceuticals LLC

After an approval-packed December solidified 2014 as one of FDA’s busiest years ever for novel drug and biologic approvals, the agency is keeping up the pace heading into 2015. In less than two months

After an approval-packed December solidified 2014 as one of FDA’s busiest years ever for novel drug and biologic approvals, the agency is keeping up the pace heading into 2015. In the first six weeks

IN VITRO DIAGNOSTICS Mergers & Acquisitions Danaher Corp. Beckman Coulter Inc. Siemens AG Siemens Healthcare Diagnostics Inc. Danaher Corp.’s Beckman Coulter Inc. bought Siemens Healthcare Diagnostics

Bexsero Clears FDA In Time For ACIP Vote FDA’s early approval of Novartis AG ’s Bexsero should allow the meningococcal group B vaccine to be considered alongside Pfizer Inc. ’s Trumenba for